Latest filing published 10 Apr 2026 for Whitehawk Therapeutics, Inc., €42k.
All filings by David James Lennon on record concern Whitehawk Therapeutics, Inc. The record holds 12 filings, for trades running from 2 October 2024 to 9 April 2026.
No open-market purchase appears, only 8 sales worth €941k. The rest of the record consists of 4 option exercises. So far in 2026, the count stands at no purchases and 6 sales.
On 10 April 2026 came the latest disclosure, an open-market sale for €42k in Whitehawk Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations